Table 1 Demographic and clinical characteristics

Sex, n (%)

Male

576 (96)

181 (78.7)

757 (91.2)

Female

24 (4)

49 (21.3)

73 (8.8)

Age at ART initiation, years old, n (%)

18–25

124 (20.7)

71 (30.9)

195 (23.5)

26–45

412 (68.7)

130 (56.5)

542 (65.3)

> 45

64 (10.7)

29 (12.6)

93 (11.2)

Median (IQR)

31.5 (27.2, 37.6)

30.8 (25.1, 39.9)

31.5 (26.9, 38.2)

Transmission, n (%)

Other

118 (19.7)

94 (40.9)

212 (25.5)

Homosexual transmission

482 (80.3)

136 (59.1)

618 (74.5)

Time from diagnosis to treatment, month, n (%)

> 1

212 (35.3)

110 (47.8)

322 (38.8)

≤ 1

388 (64.7)

120 (52.2)

508 (61.2)

Calendar time at ART initiation, n (%)

2003–2010

0 (0)

6 (2.6)

6 (0.7)

2011–2017

3 (0.5)

150 (65.2)

153 (18.4)

2018–2022

597 (99.5)

74 (32.2)

671 (80.8)

CD4 count at baseline, cells/uL, n (%)

≤ 200

141 (23.5)

87 (37.8)

228 (27.5)

> 200

459 (76.5)

143 (62.2)

602 (72.5)

Median (IQR)

344 (207, 518)

256 (101, 420.5)

312 (189, 487)

Viral load at baseline, copies/mL, n (%)

≥ 100,000

109 (18.2)

58 (25.2)

167 (20.1)

< 100,000

491 (81.8)

172 (74.8)

663 (79.9)

Median (IQR)

11,304 (52.5, 61907.5)

11836.5 (35.5, 102380.5)

11,400 (41, 70,597)